施 怡賢

Medicine & Life Sciences

1. Melanoma 100%
2. Acne Vulgaris 98%
3. Cellular Apoptosis Susceptibility Protein 85%
4. Biofilms 78%
5. durvalumab 69%
6. Microphthalmia-Associated Transcription Factor 59%
7. Vemurafenib 58%
8. Nevi and Melanomas 57%
9. Malassezia 57%
10. Folliculitis 57%
11. Lapatinib 56%
12. Drug Eruptions 56%
13. Rosacea 55%
14. Sunitinib 51%
15. Cyclic AMP Response Element-Binding Protein 50%
16. Niacinamide 50%
17. Chromosome Segregation 49%
18. Sorafenib 49%
19. Streptococcus mutans 48%
20. Phototherapy 48%
21. Deoxyribonuclease I 47%
22. Nevus 47%
23. Contact Dermatitis 47%
24. MAP Kinase Signaling System 44%
25. Tetracycline 42%
26. Endocarditis 41%
27. Interleukin-1 40%
28. Taiwan 39%
29. Phosphorylation 38%
30. Hepatitis B virus 38%
31. Proteomics 36%
32. Lamivudine 36%
33. Heterografts 36%
34. Immunosuppressive Agents 33%
35. Colorectal Neoplasms 31%
36. Real-Time Polymerase Chain Reaction 31%
37. Therapeutics 30%
38. Staining and Labeling 29%
39. Retrospective Studies 26%
40. Skin 22%
41. DNA 22%
42. Allergens 18%
43. Ligands 18%
44. Serum 18%
45. Virulence 17%
46. Antiviral Agents 17%
47. Patch Tests 16%
48. Adrenal Cortex Hormones 16%
49. Peptidylprolyl Isomerase 14%
50. Autolysis 14%